Travere Therapeutics, Inc. (NASDAQ: TVTX) has reported significant developments in its financial position and product offerings for the first quarter of 2025. Here’s a concise breakdown of key metrics and insights into the company's operations.
Key Financial Highlights:
Net product sales: $75.9 ...